WARRANTWarrant Agreement • March 1st, 2001 • Lam Pharmaceutical Corp • Pharmaceutical preparations • New York
NEITHER THIS WARRANT NOR THE SHARES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR ANY OTHER APPLICABLE SECURITIES LAWS IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION...Warrant Agreement • March 1st, 2001 • Lam Pharmaceutical Corp • Pharmaceutical preparations
COMMON STOCK PURCHASE AGREEMENT This COMMON STOCK PURCHASE AGREEMENT (this "Agreement") is dated as of January 24, 2001 by and between L.A.M. Pharmaceutical Corp., a Delaware corporation (the "Company"), and Hockbury Limited (the "Purchaser")....Common Stock Purchase Agreement • March 1st, 2001 • Lam Pharmaceutical Corp • Pharmaceutical preparations • New York
ContractSubscription Agreement • September 29th, 2016 • Easton Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Each subscriber for a Share at $0.003 Dollars per Share (the “Share”) of Easton Pharmaceuticals Inc. (Easton Pharmaceuticals) a Wyoming corporation (“the Company”), must complete and execute the Subscription Documents in accordance with the instructions set forth below. The completed documents should be sent to Easton Pharmaceuticals Inc., at 265 Rimrock Road, North York, Ontario, Canada, M3J 3C6.
EMPLOYMENT AGREEMENTEmployment Agreement • September 29th, 2016 • Easton Pharmaceuticals Inc. • Pharmaceutical preparations • Ontario
This Management and Employment Agreement, effective November 01, 2013, is entered into, by and between Easton Pharmaceuticals Inc. a Wyoming registered Corporation with offices residing in Toronto, Canada (“the Company” or “Easton”), and Carla Pepe (The “Employee”).
Form of Subscription Agreement to Purchase Common Stock and Warrants issued by the Registrant to the Selling Stockholders SUBSCRIPTION AGREEMENTSubscription Agreement • June 27th, 2005 • Lam Pharmaceutical Corp • Pharmaceutical preparations • Delaware
DISTRIBUTORSHIP AGREEMENTDistributorship Agreement • October 13th, 2004 • Lam Pharmaceutical Corp • Pharmaceutical preparations • New York
This Agreement is made as of the 30th day of January, 2004, between LAM PHARMACEUTICAL CORPORATION, a corporation subsisting under the laws of Delaware, United States of America and having a business address at 800 Sheppard Avenue West, Commercial Unit 1, Toronto, Ontario, Canada M3H 6B4 (hereinafter “LAM”) and China National Pharmaceutical Foreign Trade Corporation (SINOPHARM), a corporation subsisting under the laws of the Peoples’ Republic of China, having a business address of Unit A No. 48 Xihai Nanyan, Xicheng District, Beijing, China 100035 (hereinafter “Distributor")
EXHIBIT 10.6 AGREEMENT REGARDING SATISFACTION OF ARBITRATION AWARD This Agreement Regarding Satisfaction of Arbitration Award (the "Agreement") is made this 19th day of November, 2003 by and between L.A.M. Pharmaceutical Corp. (the "Company") and...Agreement Regarding Satisfaction of Arbitration Award • November 21st, 2003 • Lam Pharmaceutical Corp • Pharmaceutical preparations • Florida
DISTRIBUTORSHIP AGREEMENTDistributor Agreement • October 13th, 2004 • Lam Pharmaceutical Corp • Pharmaceutical preparations • New York
LAM PHARMACEUTICAL CORPORATION, a corporation subsisting under the laws of Delaware, and having a business address at 800 Sheppard Avenue West, Commercial Unit 1, Toronto, Ontario, Canada M3H 6B4.
EMPLOYMENT AGREEMENTEmployment Agreement • March 25th, 2016 • Easton Pharmaceuticals Inc. • Pharmaceutical preparations • Ontario
This Management and Employment Agreement, effective November 01, 2013, is entered into, by and between Easton Pharmaceuticals Inc. a Wyoming registered Corporation with offices residing in Toronto, Canada (“the Company” or “Easton”), and Carla Pepe (The “Employee”).
January 5, 2005Provisional Sale and Purchase Agreement • January 11th, 2005 • Lam Pharmaceutical Corp • Pharmaceutical preparations • New York
The purpose of this provisional sale and purchase letter agreement (the “Provisional Agreement”) is to outline the terms of a proposed acquisition (the “Proposed Acquisition”) by LAM Pharmaceutical Corporation (the “Acquiror”) of 51% of the outstanding shares of Hynature Investments Ltd. (“Hynature”), all of which are owned by Finest Enterprises Limited (“Seller”), on the terms and subject to the conditions to be set forth in a definitive stock purchase agreement to be executed by the parties. The proposed terms of the acquisition are as follows.
